HIV

The AJMC^® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Illicit drugs | Image credit: Stanislau_V - stock.adobe.com

SDOH Domains at Risk Correlated With Substance Use in People With HIV

By Julia Bonavitacola

May 2nd 2025

Correlation to social drivers of health (SDOH) had an important correlation with polysubstance use.

HIV | Image credit: reddish - stock.adobe.com

Family Dynamics, Mental Health Influence Adherence to ART

By Julia Bonavitacola

April 29th 2025

Richard Hughes IV, JD, MPH

What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV

By Julia Bonavitacola
Richard Hughes IV, JD, MPH

April 21st 2025

Women with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com

Poor Well-Being in HIV Associated With SDOH Adversities

By Julia Bonavitacola

April 16th 2025

Money | Image credit: Stillfx - stock.adobe.com

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

By Julia Bonavitacola

April 3rd 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.

Continuing Medical Education

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

PrEP Costs Must Come Down for Uptake to Increase, Study Says

September 26th 2020

PrEP Costs Must Come Down for Uptake to Increase, Study Says

Over a 4-year study period, the price for 30 tablets of preexposure prophylaxis (PrEP) medication increased more than 20%, potentially keeping the medication out of the hands of those most at risk for potentially contracting HIV.

Drug Resistance Mutations Increasingly Showing Up in Germany Among HIV-Positive Individuals

September 22nd 2020

Drug Resistance Mutations Increasingly Showing Up in Germany Among HIV-Positive Individuals

Despite the known benefits of antiretroviral therapy, the treatment may prove more difficult to use among clusters of patients with HIV exhibiting resistance to certain drug classes.

Remote HIV Testing, Phone Delivery of Results Has Potential Despite Drawbacks

September 19th 2020

Remote HIV Testing, Phone Delivery of Results Has Potential Despite Drawbacks

Because men who have sex with men continue to represent a disproportionate number of annual HIV diagnoses each year, a recent study investigated the utility of remote testing and phone delivery of test results among the patient group.

What We’re Reading: Restaurants Spread COVID-19; Vaccine Trials Need Black Volunteers; HIV Care Interrupted

September 16th 2020

What We’re Reading: Restaurants Spread COVID-19; Vaccine Trials Need Black Volunteers; HIV Care Interrupted

Wearing masks may not stop the spread of coronavirus disease 2019 (COVID-19) via restaurants; COVID-19 trials need more Black participants; the pandemic has disproportionately disrupted HIV care services in the South.

COVID-19 More Prevalent Among General vs HIV-Positive Population, Barcelona Study Says

September 11th 2020

COVID-19 More Prevalent Among General vs HIV-Positive Population, Barcelona Study Says

These results show that people living with HIV may not be at greater risk of contracting coronavirus disease 2019 (COVID-19) despite being immunocompromised.

Dr Anthony Fauci Speaks to the Likelihood of Vaccines for HIV and COVID-19

September 10th 2020

Dr Anthony Fauci Speaks to the Likelihood of Vaccines for HIV and COVID-19

A vaccine for coronavirus disease 2019 (COVID-19) is aspirationally possible by the end of the year and the beginning of 2021, noted Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.

Substance Use Assistance Could Be Better for HIV-Positive Individuals, Study Says

September 3rd 2020

Substance Use Assistance Could Be Better for HIV-Positive Individuals, Study Says

People with HIV are more likely to abuse injectable drugs, alcohol, and opioids, resulting in suboptimal adherence to care plans and delayed HIV diagnoses.

How Were HIV Care Services in South Carolina Interrupted by the COVID-19 Pandemic?

September 1st 2020

How Were HIV Care Services in South Carolina Interrupted by the COVID-19 Pandemic?

Results from a recent study in the state show how its HIV service care continuum was affected by the coronavirus disease 2019 pandemic (COVID-19), namely that more than a quarter of HIV clinics had to close completely.

US map

August 29th 2020

Which County-Level Factors Influence Latino HIV Disparities?

Jaime Rosenberg

Counties with a smaller proportion of Latinos faced a Latino HIV prevalence rate that was nearly 4 times that of whites, according to a recent study.

Report Identifies Factors Linked to Culturally Appropriate HIV Testing

August 26th 2020

Report Identifies Factors Linked to Culturally Appropriate HIV Testing

Jaime Rosenberg

A survey from Thailand noted that there is room for growth in HIV testing and identified the factors associated with testing.

Short-Term PrEP May Be Effective Alternative Method of HIV Prevention Among MSM

August 19th 2020

Short-Term PrEP May Be Effective Alternative Method of HIV Prevention Among MSM

Gay, bisexual, and other men who have sex with other men (MSM) during episodes of high-risk behavior could benefit from short-term use of preexposure prophylaxis (PrEP) to lessen their chances of contracting HIV, a new study reports.

MS Drug Fingolimod Shows Activity Against HIV-1, Reduces Viral Load

August 17th 2020

MS Drug Fingolimod Shows Activity Against HIV-1, Reduces Viral Load

An investigation into the use of fingolimod as antiretroviral therapy against HIV-1 revealed 2 potential targets for the immunosuppressive drug: S1P receptors and SAMHD1, an antiviral restriction factor.

Saliva May Be a Reliable Alternative to Blood for HIV Antibody Testing

August 13th 2020

Saliva May Be a Reliable Alternative to Blood for HIV Antibody Testing

HIV-specific antibodies of 3 immunoglobulin isotypes are readily found in human saliva, providing a potential second reliable method of detecting the virus that may be used as a painless alternative to a blood draw.

Physical Activity, Life Expectancy Improvements Are Most Valued HIV Treatment Outcomes, Colombian Study Says

August 10th 2020

Physical Activity, Life Expectancy Improvements Are Most Valued HIV Treatment Outcomes, Colombian Study Says

Of 5 HIV treatment effects evaluated in a recent study, short-term efficacy on physical activity ability and long-term efficacy on life expectancy were the top preferences for younger and older patients, respectively.

HIV Education, Prevention Efforts See Lukewarm Results in Dhaka, Bangladesh

August 7th 2020

HIV Education, Prevention Efforts See Lukewarm Results in Dhaka, Bangladesh

A 3-year endeavor to scale up HIV prevention and education efforts among men who have sex with men in Dhaka, Bangladesh, showed only modest gains in the country where intercourse with a same-sex partner could mean a lifetime jail sentence.

Immunosuppression to Blame for Oral Microbiota Change in Children With HIV

August 5th 2020

Immunosuppression to Blame for Oral Microbiota Change in Children With HIV

Bacterial changes in the oral cavity from immunosuppression, not HIV itself, are more likely to blame for the greater incidence of oral caries in children 6 months to 6 years, reports a study from the Department of Oral Biology at the Rutgers University School of Dental Medicine.

NIH Deems Kidney Transplantation Safe Between HIV-Positive Donors and Recipients

July 29th 2020

NIH Deems Kidney Transplantation Safe Between HIV-Positive Donors and Recipients

HIV-positive individuals with end-stage kidney disease may now have a larger pool of kidneys available to them, with recent study results from the National Institutes of Health (NIH) showing that kidneys from HIV-positive deceased donors can be used in addition to those from HIV-negative donors.

What Factors Are Most Likely to Predict Disclosing HIV Status in the Community?

July 26th 2020

What Factors Are Most Likely to Predict Disclosing HIV Status in the Community?

Having health insurance, a higher level of education, and more money were associated with a greater likelihood of caregivers disclosing their HIV status in the community, either positive or negative, while being male and living in a rural location indicated a lesser likelihood, reports AIDS Research and Therapy.

Antibody "Cocktail" Could Offer Potent Treatment, Prevention of COVID-19

July 23rd 2020

Antibody "Cocktail" Could Offer Potent Treatment, Prevention of COVID-19

Writing in Nature, scientists found the antibodies fell into 2 distinct groups, targeting different regions of the viral spike. Thus, they say, the battle against coronavirus disease 2019 (COVID-19) could be opened on separate fronts, much like the approach Ho and others have studied in HIV and some forms of cancer.

Treatment Adherence, Viral Suppression Suffer Due to HIV-Related Stigma in Florida

July 22nd 2020

Treatment Adherence, Viral Suppression Suffer Due to HIV-Related Stigma in Florida

Stigma perpetuated in a health care setting has been linked to greater odds of poor outcomes in the HIV continuum of care for antiretroviral treatment adherence and reduced viral suppression among persons living with HIV in Florida.

A Computer-Simulation Model Attempts to Reframe Costs, Solutions to Ending HIV in the United States

July 16th 2020

A Computer-Simulation Model Attempts to Reframe Costs, Solutions to Ending HIV in the United States

To effectively end the HIV epidemic in the United States, combination strategies should be tailored according to need, backed by evidence-based interventions, and scaled according to location, report study results in The Lancet HIV.

PrEP Use Has Changed Following Implementation of Social Distancing Measures

July 13th 2020

PrEP Use Has Changed Following Implementation of Social Distancing Measures

A pair of late-breaking abstracts presented during AIDS 2020, this year’s virtual meeting of the International AIDS Society, detailed the effects that the coronavirus disease 2019 pandemic has had on trends in at-risk sexual behaviors and pre-exposure prophylaxis (PrEP) use, both in the United States and in Australia, due to shelter-in-place orders and social distancing.

July 13th 2020

Having a Consistent HIV Health Care Provider and HIV-Related Clinical Outcomes

Zhi Wang, PhD Hsien-Chang Lin, PhD

The study examined the association of having a consistent HIV health care provider with related clinical outcomes, with an emphasis on a long-term physician-patient relationship.

Donor Government Funding for HIV Falls

July 9th 2020

Donor Government Funding for HIV Falls

A recent analysis conducted by the Kaiser Family Foundation and The Joint United Nations Program on HIV/AIDS found donor governments spent $7.8 billion for HIV in 2019, a decrease of $165 million from the previous year. This number is similar to that spent a decade ago, despite a 25% increase of individuals now living with HIV in regions receiving the aid.

FDA Approves HIV Drug for Adults With Multidrug-Resistant Infection

July 7th 2020

FDA Approves HIV Drug for Adults With Multidrug-Resistant Infection

Laura Joszt, MA

Patients with HIV who have been heavily treated but are failing their current regimen have few treatment options and are at risk of progressing to AIDS and death.

Study Identifies Possible New Patient Phenotype in HIV Space

July 4th 2020

Study Identifies Possible New Patient Phenotype in HIV Space

Previously associated with elite controller status, having an inherent low viral reservoir is now possibly linked to individuals with chronic HIV infection who initiate treatment with antiretrovirals more than 6 months after becoming infected.

Top 5 Most-Read News Stories During the First Half of 2020

July 3rd 2020

Top 5 Most-Read News Stories During the First Half of 2020

Between January and July 2020, The American Journal of Managed Care®’s (AJMC®) most-read stories ranged from breaking COVID-19 news to revisions of blood donation guidance.

ART May Lower Risk of COVID-19 in Persons With HIV

June 29th 2020

ART May Lower Risk of COVID-19 in Persons With HIV

Being on an antiretroviral treatment (ART) regimen of tenofovir disoproxil fumarate/emtricitabine may lower the risk of HIV-positive individuals contracting coronavirus disease 2019 (COVID-19).

PAPER OF THE WEEK: In 1998, Research Highlighted Importance of Comorbidities in HIV Care

June 28th 2020

PAPER OF THE WEEK: In 1998, Research Highlighted Importance of Comorbidities in HIV Care

These findings highlighted that adherence to drugs is not the sole issue to address in patients with comorbidities also serving as vital factors in designing managed care plans.

This Week in Managed Care: June 26, 2020

June 26th 2020

This Week in Managed Care: June 26, 2020

This week, the top managed care news included CMS proposing rules for value-based contracting in Medicaid; claims data highlighting racial disparities in COVID-19 effects; an interview with Anthony Fauci, MD, on the progress made against HIV.

...

12 13 14 15 16 17 18 19 20

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions